SCHEMBL7399499

SCHEMBL7399499

NC(C(=O)O)c1c(C(=O)O)csc1-c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
HSD17B10 Q99714 5/20 0.39
TDP1 Q9NUW8 5/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
CYP2C9 P11712 3/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2D6 P10635 1/20 0.39
GRM8 O00222 1/20 0.39
GRM6 O15303 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11261390 0.75 NPC1 (0.46) HPGDNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL8382495 0.74 DAO (0.43) HSD17B10TDP1MEN1KMT2ACYP2C9
SCHEMBL11656026 0.73 NPC1 (0.47) HPGDNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL6516769 0.70 RAB9A (0.45) HPGDNPC1RAB9AMAPTSMN1; SMN2
Ethylamine SCHEMBL6158093 0.69 NPC1 (0.58) HPGDNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL938200 0.68 RAB9A (0.47) HPGDNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL10712470 0.68 BACE1 (0.47) HPGDNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL3316024 0.66 KMT2A (0.50) HPGDMAPTSMN1; SMN2HSD17B10TDP1
SCHEMBL11254229 0.66 NPC1 (0.51) HPGDNPC1RAB9AMAPTSMN1; SMN2
SCHEMBL2261412 0.65 ALDH1A1 (0.52) HPGDMAPTSMN1; SMN2HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5863947-A Phenylglycine derivatives useful for treating disorders of the central nervous system ELI LILLY AND COMPANY LIMITED (GB) 1999-01-26 US disclosed
EP-0807621-A1 Derivatives of phenylglycine and use thereof as pharmaceuticals LILLY INDUSTRIES LIMITED (GB) 1997-11-19 EP disclosed